Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01570855 · ClinicalTrials.gov registry record
Chemotherapy Resistance and Sensitivity Testing in Lung Tumors
A clinical trial, sponsored by Marshall University.
- Completed
- Registry status
- 45
- Enrollment target
NCT01570855 is a clinical trial that has completed, run by Marshall University. The registered enrollment target is 45 participants.
The verdict
NCT01570855 has completed, sponsored by Marshall University.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to screen chemotherapy drugs currently used to treat lung cancer and determine the most effective treatment based on results of chemo sensitivity testing on the patients own cancer cells in the laboratory. The results of this screening will not influence the patients treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2011-10 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01570855
The ClinicalTrials.gov registry entry for NCT01570855 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Marshall University, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01570855 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01570855 about?
NCT01570855 is a clinical study titled "Chemotherapy Resistance and Sensitivity Testing in Lung Tumors". The purpose of this study is to screen chemotherapy drugs currently used to treat lung cancer and determine the most effective treatment based on results of chemo sensitivity testing on the patients own cancer cells in the laboratory. The results of this screening will not influence the patients tre...
What is the current status of trial NCT01570855?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2011-10. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT01570855?
This trial is sponsored by Marshall University, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.